Analysis | Metabolite Name | Measured Value | Units | subject type |
---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O] | 6320 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O] | 20929 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O] | 22041 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O] | 22391 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O] | 24372 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O] | 25877 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O] | 38060 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O] | 53095 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O] | 74536 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O] | Peak area | Healthy control | |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O] | Peak area | Mild disease | |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (2M+CL)-[-H2O] | Peak area | Severe disease | |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+CL)- | 32065 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+CL)- | 293342 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+CL)- | Peak area | Healthy control | |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+CL)- | Peak area | Mild disease | |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+CL)- | Peak area | Severe disease | |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+HCOO)- | 1471 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+HCOO)- | 1521 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+HCOO)- | 1757 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+HCOO)- | 3034 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+HCOO)- | 3425 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+HCOO)- | 3584 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+HCOO)- | 17225 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+HCOO)- | Peak area | Healthy control | |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+HCOO)- | Peak area | Mild disease | |
Reversed phase NEGATIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+HCOO)- | Peak area | Severe disease | |
Reversed phase NEGATIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+CL)- | 32065 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+CL)- | 293342 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+CL)- | Peak area | Healthy control | |
Reversed phase NEGATIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+CL)- | Peak area | Mild disease | |
Reversed phase NEGATIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+CL)- | Peak area | Severe disease | |
Reversed phase NEGATIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+HCOO)- | 1521 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+HCOO)- | 1537 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+HCOO)- | 1757 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+HCOO)- | 2303 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+HCOO)- | 3034 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+HCOO)- | 3463 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+HCOO)- | 3584 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+HCOO)- | 19795 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+HCOO)- | Peak area | Healthy control | |
Reversed phase NEGATIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+HCOO)- | Peak area | Mild disease | |
Reversed phase NEGATIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+HCOO)- | Peak area | Severe disease | |
Reversed phase POSITIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+NA)+ | 1753 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+NA)+ | 4426 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+NA)+ | 4513 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+NA)+ | 4708 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+NA)+ | 6664 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+NA)+ | 6781 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+NA)+ | 6866 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+NA)+ | 7918 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+NA)+ | 8059 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+NA)+ | 8621 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+NA)+ | 8637 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+NA)+ | 20476 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+NA)+ | 20852 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+NA)+ | 39307 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+NA)+ | Peak area | Healthy control | |
Reversed phase POSITIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+NA)+ | Peak area | Mild disease | |
Reversed phase POSITIVE ION MODE | BETA-MALTOSE (CAS# 69-79-4); (M+NA)+ | Peak area | Severe disease | |
Reversed phase POSITIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+NA)+ | 1753 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+NA)+ | 3685 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+NA)+ | 4426 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+NA)+ | 4513 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+NA)+ | 6664 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+NA)+ | 6781 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+NA)+ | 6866 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+NA)+ | 7918 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+NA)+ | 8059 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+NA)+ | 8621 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+NA)+ | 8637 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+NA)+ | 20476 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+NA)+ | 27910 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+NA)+ | 39307 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+NA)+ | Peak area | Healthy control | |
Reversed phase POSITIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+NA)+ | Peak area | Mild disease | |
Reversed phase POSITIVE ION MODE | MALTOSE (CAS# 69-79-4); (M+NA)+ | Peak area | Severe disease |